Vol. 13, No. 4 • April 2020 Dear Colleagues: Welcome to the April 2020 issue of The Journal of Clinical and Aesthetic Dermatology. We begin the issue with original research
Dear Editor: Dulaglutide is a glucagon-like peptide (GLP-1) receptor agonist, which stimulates insulin release via activation of GLP-1 receptors on pancreatic beta cells. Here, we report the first case of
J Clin Aesthet Dermatol. 2020;13(4):14–21 by Leon Kircik, MD; James Q Del Rosso, DO; Jonathan S Weiss, MD; Vassilis Stakias, PharmD; Anat London, PhD; Rita Keynan; Yohan Hazot; Russell Elliott,
J Clin Aesthet Dermatol. 2020;13(4):23–34 by Niamh Corduff, MBBS; Yates YY Chao, MD; Stephanie CK Lam, MBChB; Joyce Lim, MBBS; Ting Song Lim, MD; Kiran Lohia, MD; Isabel Mangubat, MD;
J Clin Aesthet Dermatol. 2020;13(4):36–38 by Zoe Diana Draelos, MD Dr. Draelos is with Dermatology Consulting Services, PLLC in High Point, North Carolina. FUNDING: Funding was provided by Leo Pharma.
